Juliet Dang, PhD, MS

CSL Seqirus
Summit, New Jersey, United States

Disclosure(s): CSL Seqirus: Employee, Stocks/Bonds (Public Company)

Presentation(s):

• 164 - Effectiveness of Adjuvanted Inactivated Influenza Vaccine versus High-Dose Inactivated Influenza Vaccine Against PCR-Confirmed Influenza among Adults ≥65 years: A Pragmatic Randomized Study

  Thursday, October 17, 2024
  1:45 PM – 1:57 PM US PT